Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

KROSKROS
5 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in KEROS THERAPEUTICS INC

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 233,175 shares of KROS (KEROS THERAPEUTICS INC), worth $2.5M as of 2026-Q2. The position was decreased (-60.5% shares). KROS represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$2.5M

Current Shares

233,175

Total Value Change

+$1.6M

Total Shares Change

+168,594

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
233,175
-60.5%
$2.5M0.0%$10.70
0
2026-Q1
Decreased
590,249
-55.8%
$6.5M0.0%$13.40
0
2025-Q4
Increased
1.3M
+415.8%
$27.2M0.0%$20.27
46
2025-Q3
Increased
258,754
+300.7%
$4.1M0.0%$15.95
43
2025-Q2
New
64,581
-
$862,1560.0%$13.49
34

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used